Recent News

NICE backs use of Biogen’s Zinbryta for MS

Eligible patients with multiple sclerosis should be able to get routine access to Biogen’s Zinbryta on the NHS in the next few months following a green light from cost regulators.

Eligible

Original Link...


Tags: medical, MEDICINE, pharmaceuticals
0 Volde
Report        

Read On: